Similar articles

• ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells.

  Desai SD, Reed RE, Burks J, Wood LM, Pullikuth AK, Haas AL, Liu LF, Breslin JW, Meiners S, Sankar S. Desai SD, et al. Exp Biol Med (Maywood). 2012 Jan;237(1):38-49. doi: 10.1258/ebm.2011.011236. Epub 2011 Dec 20. Exp Biol Med (Maywood). 2012. PMID: 22185919
• Regulation and action of interferon-stimulated gene 15 in breast cancer cells.

  Tecalco-Cruz AC, Ramírez-Jarquín JO, Cruz-Ramos E. Tecalco-Cruz AC, et al. Hum Cell. 2020 Oct;33(4):954-962. doi: 10.1007/s13577-020-00414-x. Epub 2020 Aug 19. Hum Cell. 2020. PMID: 32813218 Review.
• The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: friend or foe?

  Andersen JB, Hassel BA. Andersen JB, et al. Cytokine Growth Factor Rev. 2006 Dec;17(6):411-21. doi: 10.1016/j.cytogfr.2006.10.001. Epub 2006 Nov 13. Cytokine Growth Factor Rev. 2006. PMID: 17097911 Review.
• ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus.

  Osiak A, Utermöhlen O, Niendorf S, Horak I, Knobeloch KP. Osiak A, et al. Mol Cell Biol. 2005 Aug;25(15):6338-45. doi: 10.1128/MCB.25.15.6338-6345.2005. Mol Cell Biol. 2005. PMID: 16024773 Free PMC article.
• Expression, regulation and function of the ISGylation system in prostate cancer.

  Kiessling A, Hogrefe C, Erb S, Bobach C, Fuessel S, Wessjohann L, Seliger B. Kiessling A, et al. Oncogene. 2009 Jul 16;28(28):2606-20. doi: 10.1038/onc.2009.115. Epub 2009 May 11. Oncogene. 2009. PMID: 19430494